Stratos Genomics Raises $2.1M

Share

Seattle-based Stratos Genomics, developer of low-cost gene sequencing technology, says it has added $2.1 million in financing from existing investors, tied to last year’s $4 million Series A round. In a press release, CEO Allan Stephan said shareholders “don’t want our validation pace interrupted by external fundraising activities.” Stratos Genomics was founded in 2007 as a spinoff from Stratos Group, the parent company of Seattle’s Stratos Product Development.